A significant breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This essential cancer suppressor protein is frequently inactivated in many kinds of cancer, https://dftsocial.com/story23094561/nanobodies-restore-the-p53-protein-a-new-pathway-for-malignant-management